Search

This patent update relates to neurodegenerative diseases for both the peripheral and central nervous systems. Selected patent activities are described and summarised below for the period of January through June 1998. The newly disclosed agents are listed by their actual or proposed biological mechanism. While many patent applications include agents for the treatment of neurodegenerative diseases, this review cites only those patents that either disclose biological data to support potential activity, display novel structures or claim relatively unexplored mechanisms for neuroprotection.

This patent update relates to neurodegenerative diseases for both the peripheral and central nervous systems. Selected patent activities are described and summarised below for the period of July through December 1997. The newly disclosed agents are listed by their actual or proposed biological mechanism. While many patent applications include agents for the treatment of neurodegenerative diseases, this review cites only those patents which either disclose biological data to support potential activity, display novel structures or claim relatively unexplored mechanisms for neuroprotection.

This patent update relates to neurodegenerative diseases for both the peripheral and central nervous systems. Selected patent activities are described and summarised below for the period of January through June 1997. The newly disclosed agents are listed by their actual or proposed biological mechanism. While many patent applications include agents for the treatment of neurodegenerative diseases, this review cites only those patents which either disclose biological data to support potential activity, display novel structures, or claim relatively unexplored mechanisms for neuroprotection.

This patent update relates to agents for the treatment of neurodegenerative diseases, for both the peripheral and central nervous systems. Selected patent activities are described and summarised below for the period of January through June 1996. The newly disclosed agents are listed by their actual or proposed biological mechanism. While many patent applications include agents for the treatment of neurodegenerative diseases, this review cites only those patents which either disclose biological data to support potential activity, display novel structures or claim relatively unexplored mechanisms for neuroprotection.

This patent update relates to neurodegenerative diseases for both the peripheral and central nervous systems. The patenting activity is described and summarised for the period between July and December 1995. The newly disclosed agents are listed by their actual or proposed biological mechanism. While many patent applications include agents for the treatment of neurodegenerative diseases, this review cites only those patents which either disclose biological data to support potential activity, display novel structures or claim relatively unexplored mechanisms for neuroprotection.

This patent update relates to neurodegenerative diseases for both the peripheral and central nervous systems. The patenting activity is described and summarised for the period between July and December 1995. The newly disclosed agents are listed by their actual or proposed biological mechanism. While many patent applications include agents for the treatment of neurodegenerative diseases, this review cites only those patents which either disclose biological data to support potential activity, display novel structures or claim relatively unexplored mechanisms for neuroprotection.